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Recently the hitherto accepted concept of mechanism(s) of
interaction between (cortico)steroid hormones and target cells
has been modified and extended. Thus, as proposed in the case
of estrogen receptors, unoccupied and hormone occupied re-
ceptors exclusively reside in the nuclear compartment [1]. In
intact cells there is no translocation of hormone-receptor com-
plex from cytoplasm to nuclei [2]. In enucleated preparations
unoccupied receptors could be localized in the nuclear compart-
ment.
The second notion which has attracted attention is the
presence of corticosteroid metabolizing enzymes in many target
tissues. It is most likely that such enzymes are included in the
control of the cellular response to corticosteroid hormone
signals [3, 4]. An important enzyme system, 1 1/3-hydroxy-
steroid-dehydrogenase (1 l-HSD, E.C. 1.1.1.146), has recently
been implicated in mediating mineralocorticoid specificity of
corticosteroid receptors [5—7]) It is this concept we address in
the present paper. In experiments with rat renal microsomal
fractions we have tested the inhibitory effects of steroidal
inhibitors on both the apparent oxidative and reductive activity
of ll-HSD. Subsequently, isolated rat rectal epithelium has
been used in the attempt to test whether or not inhibition of
1 l-HSD might modify the apparent mineralocorticoid activity
of the endogenous rat glucocorticoid corticosterone.
Methods
Animals
Studies were performed with male Sprague-Dawley or Wistar
rats (250 to 400 g, Institut für Versuchstierkunde, Hannover,
FRG) kept on a standard rat chow and tap water ad libitum.
Biochemical studies
Rats were decapitated and the kidneys were rapidly excised.
As described elsewhere [8] a microsomal fraction was prepared
from renal homogenate by differential centrifugation. Solubili-
zation of microsomal 1 l-HSD was performed using Triton
X-100 (Boehringer, Mannheim, FRG), Zwittergent 3-10 or
CHAPS (both from Calbiochem, Frankfurt, FRG) in a concen-
tration of 1% (wt/vol) and a detergent/protein ratio of 1: 1 [9].
Microsomal fractions and supernatants were stored in 10 mM
HEPES, pH 8.0, at —20°C.
In order to study enzymatic activity of 1 l-HSD microsomes
or solubilized protein were incubated in vitro with hormone and
cosubstrate. For measuring oxidative activity corticosterone
(l0— M, Sigma, MUnchen, FRG), 1,2,6,7-3H-corticosterone
(New England Nuclear, Dreieich, FRG) and NADP (l0— M,
Boehringer) were added to the incubation medium. For mea-
suring reductive activity 1 1-dehydro-corticosterone, 3H-la-
belIed 1 1-dehydro-corticosterone (prepared and purified in our
laboratory) and NADPH were used, respectively. Hormones
and metabolites were identified by RP-HPLC as previously
described [8, 10, 11]. In similar experiments, CHAPS [9] and
/3-glycyrrhetinic acid [12] were added to the incubation medium
at various concentrations in order to test the effects on enzyme
activity of microsomal fractions.
Physiological studies
Rectal colon (the very last 3 to 4 cm of the colon) was first
"partially stripped" and then "totally stripped" of the subepi-
thelial tissues [13]. The remaining layers, epithelium plus Lam-
ma propria mucosae (Fig. 1), were mounted into conventional
Ussing-chambers [14].
The bathing fluid consisted of (mM): Na 140.5, K 5.4,
Ca 1.2, Mg 1.2, C1 123.8, HC03 21, HPO4 2.4,
H2P04 0.6, D-glucose 10, f3-OH-butyrate 0.5, glutamine 2.5,
D-mannose 10. The solution was gassed with 95% 02 plus 5%
CO2 which resulted in pH 7.4 at 37°C.
Open circuit voltage, tissue conductivity, and short circuit
current mo1 . hr . cm2) were digitally recorded every
2.5 or 10 minutes using microprocessor-driven clamp devices
(AC-microclamp, f+p Datensysteme, Aachen, FRG). The re-
sistance of the fluid between the voltage sensing electrodes was
taken into account.
l Abbreviations are: B = corticosterone, 1 1-DHB = 1 1-dehydrocor-
ticosterone, ALDO = aldosterone, 1 1-HSD = 1 1/3-hydroxysteroid-
dehydrogenase(E.C. 1.1.1.146), GLY = glycyrrhetinic acid, CHAPS =
3-[(3-cholamidopropyl)-dimethylammonio]-1-propane-sulfonate, L =
short circuit current (mol h 'cm2), Na = amiloride sensitive Na
transport (mol hcm2)
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Results
Biochemical studies
Renal microsomal fractions revealed oxidative and reductive
activities when incubated in vitro with either corticosterone or
1 1-DHB and the respective cosubstrates. This is shown in
Figure 2. Mean values of conversion were 66.0 4.8
pmol. mg' . min B into ll-DHB and 12.4 0.8
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Fig. 1. Tissue layers under investigation.
After partial and total stripping of rat rectal
colon, only epithelium and lamina propria
remains to be mounted in the Ussing
chamber.
Fig. 2. Representative experiments with rat
renal microsoma! fractions, incubated for 60
mm with B (10-i M) plus NADP (I0— M) =
oxidase, or 11-DHB (J0- M) p/us NADPH
(1O— M) = reductase. Plotted are
radiochromatograms of incubation medium.
Control = incubation of hormones and
cosubstrates without microsomal protein.
Table 1. Oxidative and reductive activities of 1 l-HSD in
supernatants of renal microsomal fractions after treatment with
different detergents (pmol mg min', N = 5) [9]
Detergent None Triton X-100 Zwittergent CHAPS
Oxidase 66.0 4.8 42.5 0.7 59.2 3.0 4.6 0.6
Reductase 12.4 0.8 14.4 0.8 16.5 2.2 8.3 1.8
Ratio ox/red 5.3 0.5 3.0 0.2 3.6 0.5 0.6 0.1
pmol. mg1 mint ll-DHB into B ( SEM, N 5). ll-HSD
activity could also be measured after extraction of the enzyme
with various detergents. Data obtained are compiled in Table 1.
Interestingly we observed that the ratio oxidative/reductive
activity differed depending on the detergent used. With Triton
X- 100 and Zwittergent the ratios obtained were comparable to
that of the unextracted microsomal fraction while CHAPS, the
apparently least effective detergent, solubilized more reductive
than oxidative activity.
Since CHAPS is a steroid derivative, we tested whether or
not this detergent might (i) preferentially solubilize reductase or
(ii) might in addition interfere with extracted oxidase activity.
The first alternative was ruled out by experiments shown in
Figure 3 [91. It could be demonstrated that oxidative as well as
reductive activity could be regenerated in vitro when Triton
X-l00 was added to a CHAPS extracted supernatant. This
maneuver resulted in a dilution of the concentration of CHAPS
to less than 0.01%. From these experiments we concluded that
CHAPS, which extracts as much protein from renal mi-
crosomes as Triton X-l00 and Zwittergent (54%, 58% and 46%,
respectively [9]), interferes with the in vitro activity of I 1-HSD,
particularly with the oxidative activity.
Experimental support for this hypothesis was obtained, when
renal microsomes were incubated in vitro with different con-
centrations of CHAPS. As shown in Figure 4A sigmoidal
inhibition curves were obtained for both the oxidative and the
reductive activity. CHAPS proved to be more effective in
inhibiting the conversion of B —* 1 l-DHB than the reverse
reaction. In Figure 4B results of similar experiments using
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Fig. 4. A. Effects of CHAPS on transformation of B 11-DHB. B.
Effects of 3-g1ycyrrhetinic acid on the transformation of B I l-DHB.
Rat renal microsomes were incubated in 10 mat HEPES solution (pH
8.0, 37°C, 60 mm, N = 8). B or I 1-DHB iO at, cosubstrate (NADPH/
NADPH) io at. Plotted are rates of transformation (100% = rate
obtained with untreated microsomes). Symbols are: (9) oxidase;
reductase.
13-glycyrrhetinic acid are shown. This drug has been reported to
inhibit specifically oxidative activity of 11-HSD 1151. The re-
suits of Figure 4B document that reductive activity is also
completely inhibited by detergent concentrations >iO at.
These biochemical studies prompted us to test the possible
biological effect of inhibition of 11-H SD on transepithelial Na
transport.
Physiological studies
After tissues were mounted in the Ussing chamber, corticos-
terone (B, 10 M) was added to both sides. As expected, I did
not increase within eight hours (Fig. 5, lower curve). After that
time l0 M amiloride was given to the mucosal side. Amiloride
caused a marginal drop in only, indicating that B did not
induce significant Na within eight hours. This is also shown in
Figure 6C. Results similar to those observed after B (without
GLY) were obtained in control experiments (no steroids added)
or after GLY (10—6 M) alone (Fig. 6, A and B).
If, in contrast, glycyrrhetinic acid (GLY, 10—6 M) was added
10 minutes prior to B (10—8 M), 'Sc started to increase two hours
later and reached maximum values after seven to eight hours
(Fig. 5, upper curve). Addition of amiloride, then, resulted in a
drop of almost to zero and indicates that most of the short
circuit current can be attributed to Na-absorption through an
apical channel. This is also depicted in Figure 6D.
Aldosterone (ALDO, 10—8 M) induced a rise in Na' in fact,
quantitatively comparable to that induced by the combination
of B and GLY (Fig. 6E). Also shown in this Figure is that the
effect of ALDO was not significantly altered by addition of
GLY (Fig. 6F). This indicates that ALDO is not affected by
ll-HSD.
Since the metabolite of B, 11-dehydrocorticosterone (11-
DHB), may also exert mineralocorticoid activity, it was tested
if this may be due to intrinsic mineralocorticoid activity or to
back-transformation to B. The apparent effect of 1 1-DHB (10
M) on Na was similar to that of ALDO (Fig. 6G), however, in
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Fig. 3. Effect of a steroidal (CHAPS) and a
non-steroidal (Triton X-IOO) detergent on
oxidative and reductive l1-HSD activity in
vitro. Incubation with 0.1% CHAPS without
or with 0.1% Triton X-l00 [9].
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a concentration range three orders of magnitude higher than
that of ALDO or B, respectively. In the presence of GLY (106
M), the mineralocorticoid activity 1 l-DHB was reduced to low
values (Fig. 6H), pointing to back-transformation as the under-
lying mechanism.
Discussion
Recently it has been reported that renal tissue from a variety
of species expresses the potency to convert endogenous corti-
costeroids (aldosterone, cortisol, corticosterone, progesterone)
as well as synthetic analogues (prednisolone, 9cr-fluorocortisol,
dexamethasone) [reviewed in 31. Using different in vitro prep-
arations of rat kidney four different metabolites of B have been
isolated and identified by HPLC and mass spectrometry [3, 4,
10, 16, 17]. From a quantitative point of view the reaction of B
1 l-DHB was most prominent. This reaction is catalyzed by
1 l-HSD, an enzyme system which could be localized in mi-
crosomal and nuclear fractions obtained from rat kidney cortex
by differential centrifugation [8].
Using solubilized enzyme protein obtained from renal ml-
crosomes a monoclonal antibody (MAb) has been raised against
rat 1 1-HSD [18]. Specificity of the MAb was documented with
a modified ELISA technique, which demonstrated that the
antibody specifically immobilized enzyme protein which upon
incubation with B or 1 l-DHB and NADP/NADPH catalyzed
the reaction B 1 l-DHB in both the oxidative as well as the
reductive directions. This is surprising, since 1 l-HSD had been
characterized as a dual enzyme system consisting of an oxidase
and a reductase, respectively [19].
Apparently then, both enzymes express a common epitope
which is recognized by our MAb. Oxidative as well as reductive
enzyme activity after delipidation with Triton X-l00 revealed a
single peak at about pH 5.9 in isoelectric focusing experiments
[9]. Western blots of solubilized enzyme revealed a single
protein band of 35 kD which was recognized by the monospe-
cific antibody [18].
Using the MAb and the APAAP staining technique [20],
11 -HSD could be localized immunohistochemically in rat renal
cryosections. Immunostaining was obtained in cells of proximal
tubules (PST > PCT) [18], a finding which is in accordance with
microbiochemical measurements on dissected single tubules
[21]. In contrast to renal cortex, the medullary staining pattern
differed: immunostaining of 1 1-HSD was confined to peritubu-
lar interstitial cells, which surround medullary tubular struc-
tures.
As to the biological relevance of 1 l-HSD in a target organ like
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curve: corticosterone (B, l0 M) plus
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10
8
Fig. 6. N, in totally stripped rectal colon.
For different experimental conditions see text.
6
4
2
0
N=7 N=8 N=6
10—6 10-8 10—8 10—6
b c d
8
iO 10—8
e f
10—6 1O iO—
g h
GLY
10—6
Hierholzer et al: Mineralocorticoid specificity of corticosteroid receptors 677
the kidney, several possibilities may be considered. As men-
tioned, highest 1 1-HSD activities were found in proximal epi-
thelia, particularly in the PST, which is a site of NADP/H-
dependent glutathion linked reaction [22]. Since in rat renal
cortex the enzyme is localized intracellularly, local transforma-
tion of B may serve signal inactivation either before or after
signal reception. Also, since 11-HSD in rat renal tissues dis-
plays both oxidative as well as reductive activity the cortico-
steroid signal may be "buffered", thus, adjusting intracellular B
concentration to the metabolic needs of the respective cells by
means of an autocrine mechanism.
The surprising finding that in renal medulla 1 l-HSD is con-
fined to interstitial cells is compatible with another concept,
that is, a paracrine role of 1 1-HSD mediated metabolism of B.
This may not, or not exclusively, modulate the interaction of B
with glucocorticoid receptors but may effect in turn also mm-
eralocorticoid receptors. Evidence comes from studies in which
liquorice, glycyrrhetinic acid or carbenoxolone has been used.
Liquorice has long been reported to cause a Conn-like syn-
drome [23], however, with a depressed renin-angiotensin-aldo-
sterone axis [24], and only in the presence of functioning
adrenals [25, 26]. The effects of liquorice were inhibitable by
spironolactone [27]. Initially it was thought that GLY, the
active principle of liquorice, binds to mineralocorticoid recep-
tors, since the compound displayed an (albeit low) affinity to
mineralocorticoid receptors [28—30]. It is now documented that
the active principle of liquorice exerts biological effects by
inhibiting the enzyme 1 l-HSD [12, 15].
Data from our laboratory (Fig. 4) demonstrate that GLY, but
also CHAPS inhibit both the apparent oxidative as well as the
reductive activity. Affinity of both inhibitors to reductase was
lower by roughly one order of magnitude. CHAPS was of
particular interest in view of the in vitro results obtained in our
laboratory (Results).
Whether or not inhibition of 1 l-HSD would modulate mm-
eralocorticoid activity in a transporting target epithelium was,
therefore, tested in order to provide evidence for the above-
mentioned concept. We used totally stripped rectal colon since
it has been shown by one of us [31] that this epithelium under
appropriate in vitro conditions is capable of transporting Na
under the influence of aldosterone for up to eight hours rou-
tinely.
Incubation of rectal epithelia which GLY led to surprising
results [32]. The steroidal compound which effectively inhibits
ll-HSD (Fig. 4B) did not affect baseline Na (Fig. 6B), but
drastically altered the response of the epithelium to corticoster-
one. B alone in 10—8 M concentration was also ineffective in
stimulating Na, but the two apparently ineffective steroidal
substances together resulted an aldosterone-like effect on Na
Thus, GLY uncovered the "true" mineralocorticoid potency of
B, which turned out to be not significantly different from that of
the typical mineralocorticoid, ALDO. Since GLY blocks 11-
HSD, it can be stated in turn that it is 11-H SD localized within
totally stripped rectal colon, which prevents mineralocorticoid
receptors of this target tissue to be occupied by glucocorticoids.
The effect of aldosterone on Na was not altered by GLY.
This can be attributed to the fact that ALDO in its half-acetal
configuration is prevented from being attacked by 11-H SD.
The apparent mineralocorticoid potency of 1 1-DHB is not
intrinsic but is due to local back-transformation to B, catalyzed
by 1 l-HSD. This can be derived from the experiments shown in
Figure 6, G and H, respectively. ll-DHB in pharmacologic
concentration could not stimulate Na when added together with
GLY. Thus, the observed effect of 1 1-DHB alone is attributed
to back-transformation of 1 l-DHB into B. Thus, in the biolog-
ical experiment local 11 -HSD catalyzes both the oxidative and
the reductive reaction, and GLY blocks both reactions.
In summary, the present results document that an inhibitor of
ll-HSD is able to effectively convert an endogenous glucocor-
ticoid in low concentration (l08 M) into an effective mm-
eralocorticoid. We attribute this action to a complete inhibition
of 11 f3-hydroxysteroid oxidase activity which leads to the loss
of a metabolic barrier normally preventing B (but not ALDO)
from binding to mineralocorticoid receptors. Apparently, the
receptor by itself is unable to discriminate between corticoster-
one and aldosterone. We demonstrate in a biological experi-
ment that glucocorticoid metabolizing enzymes, present in
effective concentration within the target tissue, are responsible
for distinguishing between glucocorticoids and mineralocorti-
coids.
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